您当前的位置:
首页 >
文章列表页 >
Treatment of Liver Cancer by Intervening TGF-β Signaling Pathway with Traditional Chinese Medicine: A Review
更新时间:2026-03-19
    • Treatment of Liver Cancer by Intervening TGF-β Signaling Pathway with Traditional Chinese Medicine: A Review

      增强出版
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 32, Issue 8, Pages: 318-326(2026)
    • DOI:10.13422/j.cnki.syfjx.20251323    

      CLC: R256;R287;R735.7
    • Received:10 March 2025

      Revised:2025-04-22

      Accepted:30 April 2025

      Online First:07 May 2025

      Published:20 April 2026

    移动端阅览

  • CHENG Hao,GUO Haohao,SUN Jun,et al.Treatment of Liver Cancer by Intervening TGF-β Signaling Pathway with Traditional Chinese Medicine: A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(08):318-326. DOI: 10.13422/j.cnki.syfjx.20251323.

  •  
  •  

0

Views

19

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Traditional Chinese Medicine for Hepatocellular Carcinoma Treatment Based on NF-κB Signaling Pathway: A Review
Regulation of Relevant Signaling Pathways by Traditional Chinese Medicine in Intervention of Pancreatic Cancer: A Review
Signaling Pathways Related to Traditional Chinese Medicine Intervention in Hashimoto's Thyroiditis: A Review
TCM Treatment of Lung Cancer Based on AMPK Signaling Pathway: A Review

Related Author

CHENG Hao
SUN Jun
LI Shiyi
DING Yuxue
YUE Huaqiang
YANG Ren
LI Mengge
DANG Zhibo

Related Institution

Hubei University of Chinese Medicine
Henan University of Chinese Medicine
Henan Province Hospital of Traditional Chinese Medicine
School of Pharmacy, Henan University of Chinese Medicine
Henan Collaborative Innovation Center for Full Industrial Chain Research and Development of Yu Medicinals, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine
0